***** *** ********* GLAUCOMA ** *** Progress Note */**/****     Problem Overview(s):  Patient Active Problem List      • Primary open angle glaucoma of both eyes, mild stage [H40.1131]     Glaucoma Summary:  Gonio: open to CBB  Tmax: 25 OD 32 OS   CCT: ***/***  **** Allergies/Intolerances:Brimonidine - light sensitivity, Many drug sensitivities     Visual ***** ************** (*** */**/****)  ******** 24-2 visual field  OD full, MD -1.42, stable  OS light inferior paracentral scotoma, MD -1.06, light paracentral changes x2    *** interpretation (*/**/****)  Type:  Spectralis     OD nasal thinning, average RNFL thickness 73  **, baseline some temporal shift   OS nasal thinning, average RNFL thickness 78  **, baseline some temporal shift        Assessment & Plan: 51 y.o. female   Primary open angle glaucoma of both eyes, mild stage  Follows with Dr. ******** (****) q 6 months  ***-A progression study participant, seen ****  - ONH glaucomatous in appearance with thin rim  - IOP stable in teens on latanoprost, thin CCT  - *** baseline last ******  - */**/**** HVF 24-2 with paracentral scotoma x 2 now and stable.   - **-* next visit  - cont. Latanoprost for now.           Call for decreased vision, increased distortion, increased pain, new floaters or flashing lights  Follow up: Return in about 3 months (around */**/****) for w/HVF **-*, w/RNFL.         Chief Complaint: Follow-up visit    HPI: 3 months for *****-2..I have attempted to contact this patient by telephone, but there is no answer repeatedly. I will continue to try later.     No **-* today per Dr. ***. Only 24-2 for study    Noticed difficulty in seeing fine print when CLs on. Feels like the glass prescription would have changed a bit. No other concerns today.    Eye Meds:   Latanoprost nightly BOTH eyes -  Last night 10pm  AT PRN     No occupation listed.    Current Outpatient Medications (Other)   Medication Sig   • etonogestreL-ethinyl estradioL Place 1 each into the vagina every four weeks. Following intravaginal insertion, ring should remain in place for 3 weeks, then removed for 1 week. A new ring is inserted 7 days after the last was removed.   • loratadine Take 10 mg by mouth once daily.   • Lysine Take 1,000 mg by mouth once daily.   • MEDICATION HELP once daily. Adrenal Support   • MULTIVITAMIN ORAL Take  by mouth once daily.   • NALTREXONE HCL (NALTREXONE ORAL) Take  by mouth. 1.5mg nightly     Reviewed: Tobacco |         Examination: See Ophthalmology Module  ************:  The attending physician is responsible for and agrees with the entire content of the note and has personally performed the HPI and the physical examination.    ****** * ***, MD  